Barts and The London, School of Medicine and Dentistry

Be able to describe alterations in cholinergic neurotransmission in Alzheimer's disease.

Level

This learning outcome is a primary level outcome.

Assessment

This learning outcome is assessed in the following ways:

GMC theme

This learning outcome maps to the following GMC theme: